---

Mucormycosis outbreak in India - What lead us to this crisis?

---

Original Article

Author Details : Rachana Prasad*, Sachana Prasad, Ratna Kumari, Komal khalkho, Rajesh Kumar Choudhary

Volume : 5, Issue : 2, Year : 2022

Article Page : 26-29

https://doi.org/10.18231/j.ijoas.2022.008

Suggest article by email

Get Permission

---

Abstract

This is a retrospective study analysing the demographics, clinical characteristics, radiological findings and treatment of the 54 patients of rhino-sino-orbital or cerebral mucormycosis in a tertiary health care centre in Jharkhand. All patients with probable or proven mucormycosis were included in the study. A significant number (45%) of patients belonged to rural areas. About 20% of patients did not give history of COVID infection denoting association of mucormycosis in mild or asymptomatic COVID patients. There was a delay of approximately 11 days in seeking medical care leading to poorer outcome in patients. Diabetes was a major risk factor associated with 83% of the patients. Steroid was given as treatment in 80%of the patients who had COVID - 19. Extensive disease was seen in 37% of the patients suggesting that the mucormycosis was more devastating during the outbreak as compared to pre- covid times.
 

Keywords: Mucormycosis, Black fungus, COVID­19, Coronavirus

How to cite : Prasad R, Prasad S, Kumari R, Khalkho K, Choudhary R K, Mucormycosis outbreak in India - What lead us to this crisis?. J Otorhinolaryngol Allied Sci 2022;5(2):26-29

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.